Claudin-2 expression increases tumorigenicity of colon cancer cells

Role of epidermal growth factor receptor activation

Punita Dhawan, R. Ahmad, R. Chaturvedi, J. J. Smith, R. Midha, M. K. Mittal, M. Krishnan, X. Chen, S. Eschrich, T. J. Yeatman, R. C. Harris, M. K. Washington, K. T. Wilson, R. D. Beauchamp, Amar Bahadur Singh

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Claudin-2 is a unique member of the claudin family of transmembrane proteins, as its expression is restricted to the leaky epithelium in vivo and correlates with epithelial leakiness in vitro. However, recent evidence suggests potential functions of claudin-2 that are relevant to neoplastic transformation and growth. In accordance, here we report, on the basis of analysis of mRNA and protein expression using a total of 309 patient samples that claudin-2 expression is significantly increased in colorectal cancer and correlates with cancer progression. We also report similar increases in claudin-2 expression in inflammatory bowel disease-associated colorectal cancer. Most importantly, we demonstrate that the increased claudin-2 expression in colorectal cancer is causally associated with tumor growth as forced claudin-2 expression in colon cancer cells that do not express claudin-2 resulted in significant increases in cell proliferation, anchorage-independent growth and tumor growth in vivo. We further show that the colonic microenvironment regulates claudin-2 expression in a manner dependent on signaling through the EGF receptor (EGFR), a key regulator of colon tumorigenesis. In addition, claudin-2 expression is specifically decreased in the colon of waved-2 mice, naturally deficient in EGFR activation. Furthermore, genetic silencing of claudin-2 expression in Caco-2, a colon cancer cell line, prevents the EGF-induced increase in cell proliferation. Taken together, these results uncover a novel role for claudin-2 in promoting colon cancer, potentially via EGFR transactivation.

Original languageEnglish (US)
Pages (from-to)3234-3247
Number of pages14
JournalOncogene
Volume30
Issue number29
DOIs
StatePublished - Jul 21 2011

Fingerprint

Claudin-2
Epidermal Growth Factor Receptor
Colonic Neoplasms
Colorectal Neoplasms
Growth
Colon
Cell Proliferation
Neoplasms
Inflammatory Bowel Diseases
Epidermal Growth Factor
Transcriptional Activation

Keywords

  • EGFR
  • claudin
  • colon cancer
  • proliferation
  • tight junction

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Claudin-2 expression increases tumorigenicity of colon cancer cells : Role of epidermal growth factor receptor activation. / Dhawan, Punita; Ahmad, R.; Chaturvedi, R.; Smith, J. J.; Midha, R.; Mittal, M. K.; Krishnan, M.; Chen, X.; Eschrich, S.; Yeatman, T. J.; Harris, R. C.; Washington, M. K.; Wilson, K. T.; Beauchamp, R. D.; Singh, Amar Bahadur.

In: Oncogene, Vol. 30, No. 29, 21.07.2011, p. 3234-3247.

Research output: Contribution to journalArticle

Dhawan, P, Ahmad, R, Chaturvedi, R, Smith, JJ, Midha, R, Mittal, MK, Krishnan, M, Chen, X, Eschrich, S, Yeatman, TJ, Harris, RC, Washington, MK, Wilson, KT, Beauchamp, RD & Singh, AB 2011, 'Claudin-2 expression increases tumorigenicity of colon cancer cells: Role of epidermal growth factor receptor activation', Oncogene, vol. 30, no. 29, pp. 3234-3247. https://doi.org/10.1038/onc.2011.43
Dhawan, Punita ; Ahmad, R. ; Chaturvedi, R. ; Smith, J. J. ; Midha, R. ; Mittal, M. K. ; Krishnan, M. ; Chen, X. ; Eschrich, S. ; Yeatman, T. J. ; Harris, R. C. ; Washington, M. K. ; Wilson, K. T. ; Beauchamp, R. D. ; Singh, Amar Bahadur. / Claudin-2 expression increases tumorigenicity of colon cancer cells : Role of epidermal growth factor receptor activation. In: Oncogene. 2011 ; Vol. 30, No. 29. pp. 3234-3247.
@article{d1f387831fef48df95e43bd0fc2469ee,
title = "Claudin-2 expression increases tumorigenicity of colon cancer cells: Role of epidermal growth factor receptor activation",
abstract = "Claudin-2 is a unique member of the claudin family of transmembrane proteins, as its expression is restricted to the leaky epithelium in vivo and correlates with epithelial leakiness in vitro. However, recent evidence suggests potential functions of claudin-2 that are relevant to neoplastic transformation and growth. In accordance, here we report, on the basis of analysis of mRNA and protein expression using a total of 309 patient samples that claudin-2 expression is significantly increased in colorectal cancer and correlates with cancer progression. We also report similar increases in claudin-2 expression in inflammatory bowel disease-associated colorectal cancer. Most importantly, we demonstrate that the increased claudin-2 expression in colorectal cancer is causally associated with tumor growth as forced claudin-2 expression in colon cancer cells that do not express claudin-2 resulted in significant increases in cell proliferation, anchorage-independent growth and tumor growth in vivo. We further show that the colonic microenvironment regulates claudin-2 expression in a manner dependent on signaling through the EGF receptor (EGFR), a key regulator of colon tumorigenesis. In addition, claudin-2 expression is specifically decreased in the colon of waved-2 mice, naturally deficient in EGFR activation. Furthermore, genetic silencing of claudin-2 expression in Caco-2, a colon cancer cell line, prevents the EGF-induced increase in cell proliferation. Taken together, these results uncover a novel role for claudin-2 in promoting colon cancer, potentially via EGFR transactivation.",
keywords = "EGFR, claudin, colon cancer, proliferation, tight junction",
author = "Punita Dhawan and R. Ahmad and R. Chaturvedi and Smith, {J. J.} and R. Midha and Mittal, {M. K.} and M. Krishnan and X. Chen and S. Eschrich and Yeatman, {T. J.} and Harris, {R. C.} and Washington, {M. K.} and Wilson, {K. T.} and Beauchamp, {R. D.} and Singh, {Amar Bahadur}",
year = "2011",
month = "7",
day = "21",
doi = "10.1038/onc.2011.43",
language = "English (US)",
volume = "30",
pages = "3234--3247",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "29",

}

TY - JOUR

T1 - Claudin-2 expression increases tumorigenicity of colon cancer cells

T2 - Role of epidermal growth factor receptor activation

AU - Dhawan, Punita

AU - Ahmad, R.

AU - Chaturvedi, R.

AU - Smith, J. J.

AU - Midha, R.

AU - Mittal, M. K.

AU - Krishnan, M.

AU - Chen, X.

AU - Eschrich, S.

AU - Yeatman, T. J.

AU - Harris, R. C.

AU - Washington, M. K.

AU - Wilson, K. T.

AU - Beauchamp, R. D.

AU - Singh, Amar Bahadur

PY - 2011/7/21

Y1 - 2011/7/21

N2 - Claudin-2 is a unique member of the claudin family of transmembrane proteins, as its expression is restricted to the leaky epithelium in vivo and correlates with epithelial leakiness in vitro. However, recent evidence suggests potential functions of claudin-2 that are relevant to neoplastic transformation and growth. In accordance, here we report, on the basis of analysis of mRNA and protein expression using a total of 309 patient samples that claudin-2 expression is significantly increased in colorectal cancer and correlates with cancer progression. We also report similar increases in claudin-2 expression in inflammatory bowel disease-associated colorectal cancer. Most importantly, we demonstrate that the increased claudin-2 expression in colorectal cancer is causally associated with tumor growth as forced claudin-2 expression in colon cancer cells that do not express claudin-2 resulted in significant increases in cell proliferation, anchorage-independent growth and tumor growth in vivo. We further show that the colonic microenvironment regulates claudin-2 expression in a manner dependent on signaling through the EGF receptor (EGFR), a key regulator of colon tumorigenesis. In addition, claudin-2 expression is specifically decreased in the colon of waved-2 mice, naturally deficient in EGFR activation. Furthermore, genetic silencing of claudin-2 expression in Caco-2, a colon cancer cell line, prevents the EGF-induced increase in cell proliferation. Taken together, these results uncover a novel role for claudin-2 in promoting colon cancer, potentially via EGFR transactivation.

AB - Claudin-2 is a unique member of the claudin family of transmembrane proteins, as its expression is restricted to the leaky epithelium in vivo and correlates with epithelial leakiness in vitro. However, recent evidence suggests potential functions of claudin-2 that are relevant to neoplastic transformation and growth. In accordance, here we report, on the basis of analysis of mRNA and protein expression using a total of 309 patient samples that claudin-2 expression is significantly increased in colorectal cancer and correlates with cancer progression. We also report similar increases in claudin-2 expression in inflammatory bowel disease-associated colorectal cancer. Most importantly, we demonstrate that the increased claudin-2 expression in colorectal cancer is causally associated with tumor growth as forced claudin-2 expression in colon cancer cells that do not express claudin-2 resulted in significant increases in cell proliferation, anchorage-independent growth and tumor growth in vivo. We further show that the colonic microenvironment regulates claudin-2 expression in a manner dependent on signaling through the EGF receptor (EGFR), a key regulator of colon tumorigenesis. In addition, claudin-2 expression is specifically decreased in the colon of waved-2 mice, naturally deficient in EGFR activation. Furthermore, genetic silencing of claudin-2 expression in Caco-2, a colon cancer cell line, prevents the EGF-induced increase in cell proliferation. Taken together, these results uncover a novel role for claudin-2 in promoting colon cancer, potentially via EGFR transactivation.

KW - EGFR

KW - claudin

KW - colon cancer

KW - proliferation

KW - tight junction

UR - http://www.scopus.com/inward/record.url?scp=79960706000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960706000&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.43

DO - 10.1038/onc.2011.43

M3 - Article

VL - 30

SP - 3234

EP - 3247

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 29

ER -